知识转化实践:提升非小细胞肺癌分子检测意识
研究针对诊断专家开展知识转化干预,以提高对肺癌分子检测及适当诊断采样的理解。通过省级和全国专科会议实施教育项目,干预前后进行匿名问卷调查,并评估安大略省EGFR检测率变化。结果显示干预后专家知识显著改善,不确定感从30%降至2%,EGFR检测请求相对增加57%。
要点
- 干预前30%诊断专家不确定分子检测的组织处理方法。
- 干预后组织处理与固定技术知识改善,不确定感降至2%。
- 干预期间安大略省EGFR检测请求相对增加57%。
核心结论
- 诊断专家在肺癌分子检测和靶向治疗方面存在显著知识缺口,该干预显著提升了对成功分子检测重要性和方法的理解,并与检测率增加相关。
研究设计与样本
- 基于文献和加拿大专家意见开发专科教育项目,在省级和全国专科会议上实施,通过匿名问卷评估干预前后知识,并评估安大略省干预前后EGFR检测率。
主要发现
- 基线时30%不确定分子检测的组织处理方法,20%选择了错误技术,一半不熟悉如何启动检测。
- 干预后组织处理和适当固定技术知识改善,不确定感从30%降至2%(p < 0.001)。
- 干预期间安大略省分子(EGFR)检测请求增加12%(相对增加57%)(p = 0.0032)。
临床怎么用
- 可通过专科会议开展知识转化教育项目,提升诊断专家对肺癌分子检测和组织处理的认识,并可能提高检测率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Molecular testing in advanced lung cancer is standard in guiding treatment selection. However, population-wide implementation of testing remains a challenge. We developed a knowledge translation intervention to improve understanding among diagnostic specialists about molecular testing and appropriate diagnostic sampling in lung cancer. METHODS: Specialty-specific education programs were developed from existing literature and input from Canadian leaders in lung pathology, respirology, interventional radiology, thoracic surgery, radiation oncology, and medical oncology. The programs, including key messages, review of current data, existing guidelines, group discussion, and participant feedback, were administered at provincial and national specialty meetings. Participant knowledge was assessed before and after the intervention by using anonymous questionnaires. Molecular (EGFR) testing rates in Ontario were also evaluated before and after the intervention period. RESULTS: Ten programs were administered to diagnostic specialists, including respirologists, pathologists, thoracic surgeons, radiologists, radiation oncologists, and medical oncologists, with completion of 255 preintervention and 219 postintervention surveys. At baseline, 30% were unsure of tissue handling methods for molecular testing, 20% chose an incorrect technique, and half were unfamiliar with how to initiate testing. After intervention, specialist knowledge improved regarding tissue handling and appropriate fixation techniques and uncertainty decreased from 30% to 2% (p < 0.001). A 12% increase (relative increase 57%) in molecular (EGFR) testing requests in Ontario was observed over the intervention period (p = 0.0032). CONCLUSIONS: Significant knowledge gaps exist among diagnostic specialists regarding molecular testing and targeted therapy in lung cancer. This initiative significantly improved understanding of the importance and methods of successful molecular testing and correlated with increased testing rates.
引用
- Zer A, Cutz JC, Sekhon H, et al. Translation of Knowledge to Practice-Improving Awareness in NSCLC Molecular Testing. J Thorac Oncol. 2018. PMID: 29535011. doi:10.1016/j.jtho.2018.03.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。